Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate in osteopenic postmenopausal women
NCT00353080Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2002
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of risedronate in osteoporosis, sponsored by Sanofi. Started Dec 2002; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00353080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353080.